
A multicenter study compared polymyxin B (PMB) and colistin sulfate (CS) for carbapenem-resistant Acinetobacter baumannii (CRAB) pneumonia in ICU patients. Both showed similar efficacy and risk of kidney and liver toxicity, but PMB had a significantly higher rate of skin toxicity. Findings highlight the need for careful patient monitoring and optimized treatment duration to improve outcomes.
Like
Save
Share